NanoViricides
NNVC
34 hedge funds and large institutions have $2.31M invested in NanoViricides in 2024 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 4 closing their positions.
125% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 4
67% more capital invested
Capital invested by funds: $1.38M → $2.31M (+$926K)
25% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 4
17% more funds holding
Funds holding: 29 → 34 (+5)
1.24% more ownership
Funds ownership: 10.14% → 11.38% (+1.2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$92.6K |
| 2 |
IWC
Integrated Wealth Concepts
Waltham,
Massachusetts
|
+$65.6K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$39.8K |
| 4 |
Renaissance Technologies
New York
|
+$31.3K |
| 5 |
MAWA
Moss Adams Wealth Advisors
Seattle,
Washington
|
+$26.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$24.9K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$1.71K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$490 |
| 4 |
Simplex Trading
Chicago,
Illinois
|
-$242 |
| 5 |
Wells Fargo
San Francisco,
California
|
-$157 |
NNVC Hedge Fund Activity: Q2 2024 in Review
34 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in NanoViricides (NNVC) for Q2 2024, worth a combined $2.31M — up 67% from $1.38M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new NNVC positions and 4 closed out — a net gain of 5 holders — while 5 added to existing stakes and 4 trimmed.
The largest buyer was Vanguard Group, adding an estimated $92.6K. The largest seller was Citadel Advisors, exiting entirely with an estimated $24.9K sold.
- 34 institutional investors held NanoViricides (NNVC) as of Q2 2024, up from 29 in Q1 2024.
- Funds reported $2.31M of NanoViricides stock for Q2 2024, up 67% quarter-over-quarter.
- 9 funds opened new NanoViricides positions in Q2 2024 and 4 closed out, a net change of +5 holders.
- The largest NanoViricides buyer in Q2 2024 was Vanguard Group, an estimated $92.6K added.
- The largest NanoViricides seller in Q2 2024 was Citadel Advisors, an estimated $24.9K sold.
Based on aggregated 13F filings for Q2 2024.